Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Y M, Hijazi"'
Publikováno v:
Cancer. 87(1)
HMB-45, an antibody directed against a premelanosome glycoprotein, has thus far been considered the most specific antibody for the immunocytochemical substantiation of the diagnosis of malignant melanoma (MM). A recently described antigen, MART-1, is
Publikováno v:
Cancer. 84(2)
The distinction between malignant mesothelioma (MM) and adenocarcinoma (ACA) in cytologic specimens frequently is difficult, often requiring immunocytochemistry to support the diagnosis. Recent reports have proposed the utilization of antibodies to m
Autor:
J N, Cormier, Y M, Hijazi, A, Abati, P, Fetsch, M, Bettinotti, S M, Steinberg, S A, Rosenberg, F M, Marincola
Publikováno v:
International journal of cancer. 75(4)
MART-1/MelanA and Pmel17/gp100 are melanoma-associated antigens (MAAs) that can be recognized by tumor-infiltrating lymphocytes (TILs) capable of mediating successful adoptive therapy in vivo. Analysis of melanoma cell lines in vitro has demonstrated
Autor:
B J, Czerniecki, C, Carter, L, Rivoltini, G K, Koski, H I, Kim, D E, Weng, J G, Roros, Y M, Hijazi, S, Xu, S A, Rosenberg, P A, Cohen
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 159(8)
Human peripheral blood contains a small subpopulation of immature dendritic cells (iDC) distinguished from circulating monocytes by their low expression of CD14. We utilized leukapheresis and countercurrent centrifugal elutriation to obtain myeloid o
Autor:
R D, Dadmarz, A, Ordoubadi, A, Mixon, C O, Thompson, K C, Barracchini, Y M, Hijazi, M A, Steller, S A, Rosenberg, D J, Schwartzentruber
Publikováno v:
The cancer journal from Scientific American. 2(5)
To search for tumor-specific in vitro reactivity by lymphocytes derived from patients with ovarian carcinoma.Tumor-infiltrating lymphocytes (TIL) were derived from primary or metastatic solid tumors and tumor-associated lymphocytes (TAL) were derived
Autor:
L H, Wexler, T F, DeLaney, M, Tsokos, N, Avila, S M, Steinberg, L, Weaver-McClure, J, Jacobson, P, Jarosinski, Y M, Hijazi, F M, Balis, M E, Horowitz
Publikováno v:
Cancer. 78(4)
This study was conducted to determine the feasibility of, and improve outcome by, incorporating ifosfamide and etoposide (IE) into the therapy of newly diagnosed patients with Ewing's sarcoma family of tumors of bone and soft tissue.Fifty-four newly
Publikováno v:
Diagnostic cytopathology. 14(4)
Photodynamic therapy (PDT) has been used in phase I clinical trials at the National Institutes of Health for the treatment of malignancies disseminated within the peritoneal and pleural cavities. Review of records revealed 18 patients who were treate
Autor:
F M, Marincola, Y M, Hijazi, P, Fetsch, M L, Salgaller, L, Rivoltini, J, Cormier, T B, Simonis, P H, Duray, M, Herlyn, Y, Kawakami, S A, Rosenberg
Publikováno v:
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy. 19(3)
MART-1 and gp100 melanoma associated antigens (MAA) are expressed by cells of the melanocytic lineage and are recognized by the majority of HLA-A2 restricted tumor-infiltrating lymphocytes. Heterogeneity of expression of MAA in tumor deposits may aff
Autor:
Irina A. Lubensky, Claire W. Hallahan, Anthony S. Fauci, Y M Hijazi, M. M. Walther, W. M. Linehan, Gail S. Kerr, Gary S. Hoffman, Michael C. Sneller, Cheryl Talar-Williams
Publikováno v:
Annals of internal medicine. 124(5)
To describe the incidence of, clinical manifestations of, and risk factors for cyclophosphamide-induced urinary bladder toxicity in patients treated for nonmalignant disease.Retrospective analysis of patients followed at the National Institutes of Al
Autor:
Nakisa A; Department of Chemistry, Michigan State University, East Lansing, Michigan, 48824, United States.; Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, Michigan, 48824, United States., Sempere LF; Precision Health Program and Department of Radiology, Michigan State University, East Lansing, Michigan, 48824, United States., Chen X; Department of Chemistry, University of California, Davis, California, 95616, USA., Qu LT; Department of Surgery, Michigan State University, East Lansing, Michigan, 48824, United States., Woldring D; Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, Michigan, 48824, United States.; Department of Chemical Engineering and Materials Science, Michigan State University, East Lansing, Michigan, 48824, United States., Crawford HC; Department of Surgery, Henry Ford Health System, Detroit, Michigan, 48202, United States.; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, 48824, United States., Huang X; Department of Chemistry, Michigan State University, East Lansing, Michigan, 48824, United States.; Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, Michigan, 48824, United States.; Department of Biomedical Engineering, Michigan State University, East Lansing, Michigan, 48824, United States.
Publikováno v:
ChemMedChem [ChemMedChem] 2024 Sep 04, pp. e202400491. Date of Electronic Publication: 2024 Sep 04.